4.56
price down icon4.00%   -0.19
pre-market  시장 영업 전:  4.46   -0.10   -2.19%
loading
전일 마감가:
$4.75
열려 있는:
$4.71
하루 거래량:
841.06K
Relative Volume:
1.38
시가총액:
$441.77M
수익:
-
순이익/손실:
$-238.77M
주가수익비율:
-0.1701
EPS:
-26.808
순현금흐름:
$-216.62M
1주 성능:
-5.20%
1개월 성능:
+13.43%
6개월 성능:
-0.65%
1년 성능:
-59.68%
1일 변동 폭
Value
$4.385
$4.75
1주일 범위
Value
$4.385
$4.88
52주 변동 폭
Value
$2.7601
$13.00

Alumis Inc Stock (ALMS) Company Profile

Name
명칭
Alumis Inc
Name
전화
650-231-6625
Name
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Name
직원
252
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
ALMS's Discussions on Twitter

ALMS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ALMS
Alumis Inc
4.56 494.31M 0 -238.77M -216.62M -26.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Alumis Inc Stock (ALMS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-25 개시 Wells Fargo Overweight
2025-06-10 재개 Guggenheim Buy
2025-01-30 개시 Oppenheimer Outperform
2024-10-31 개시 Robert W. Baird Outperform
2024-10-17 개시 H.C. Wainwright Buy
2024-07-23 개시 Cantor Fitzgerald Overweight
2024-07-23 개시 Guggenheim Buy
2024-07-23 개시 Leerink Partners Outperform
2024-07-23 개시 Morgan Stanley Overweight
모두보기

Alumis Inc 주식(ALMS)의 최신 뉴스

pulisher
Nov 03, 2025

Is a relief rally coming for Alumis Inc. holdersQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN

Oct 30, 2025
pulisher
Oct 28, 2025

Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará

Oct 28, 2025

Alumis Inc (ALMS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Alumis Inc 주식 (ALMS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Tananbaum James B.
Director
May 06 '25
Buy
4.34
20,000
86,800
4,247,670
Foresite Labs, LLC
10% Owner
May 02 '25
Buy
4.62
25,000
115,500
4,227,670
Foresite Labs, LLC
10% Owner
May 06 '25
Buy
4.34
20,000
86,800
4,247,670
Foresite Capital Management VI
10% Owner
May 02 '25
Buy
4.62
25,000
115,500
4,227,670
Foresite Capital Management VI
10% Owner
May 06 '25
Buy
4.34
20,000
86,800
4,247,670
AKKARAJU SRINIVAS
Director
May 05 '25
Buy
4.67
160,370
749,676
3,586,788
AKKARAJU SRINIVAS
Director
May 02 '25
Buy
4.55
159,920
727,636
3,426,418
Colowick Alan
Director
Apr 01 '25
Buy
6.97
16,104
112,309
16,104
Colowick Alan
Director
Apr 02 '25
Buy
7.49
2,300
17,235
18,404
Babler Martin
President, CEO and Chairman
Apr 01 '25
Buy
6.44
15,650
100,733
106,454
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):